- Description
- Table of Contents
- Request Sample
The Monoclonal Antibodies market is expected to reach $183.35 billion by 2026 growing at a CAGR of 8.3% during 2018 to 2026. Monoclonal is a class of antibodies with identical offspring of a hybridoma. These are derived by cell division from a single parent cell. Monoclonal antibodies are used in the diagnosis of leukemia and more recently in the treatment of malignancies. Factors such as constant innovation in drug development and discovery, increased need for personalized medicine, and growing R&D activities in genomics are driving the market growth. Though, the high cost of antibodies restrains the market growth. Moreover, the high rate of adoption of therapeutic antibodies and favourable regulatory policies are the opportunities for the monoclonal antibodies market. Based on source type, the humanized segment is going to have a lucrative growth during the forecast period, owing to its extensive adoption in the treatment of various diseases including cancer, inflammatory, and autoimmune diseases. The key vendors mentioned are Abbott Laboratories, GlaxoSmithKline Plc, Pfizer , Novartis International, Merck & Co Inc, Johnson & Johnson, Eli Lilly, Amgen Inc, Daiichi Sankyo, AstraZeneca Plc, Thermo Fisher Scientific, Biogen Idec Inc, Mylan N.V, Bayer AG, F.Hoffman-La Roche Ltd, and Bristol Myers Squibb. Source Types Covered: • Human • Humanized • Recombinant • Chimeric • Murine Production Types Covered: • In Vivo • In Vitro Indications Covered: • Hematological Disorders • Autoimmune Diseases • Cancer • Infectious Diseases • Neurology • Cardiovascular • Microbial Diseases • Inflammatory Diseases • Respiratory Diseases Applications Covered: • Analytical & Chemical Uses • Therapeutic • Diagnostic End Users Covered: • Research Institutes • Hospitals & Clinics Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analysed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Monoclonal Antibodies Market, By Source Type
5.1 Introduction
5.2 Human
5.3 Humanized
5.4 Recombinant
5.5 Chimeric
5.6 Murine
6 Global Monoclonal Antibodies Market, By Production Type
6.1 Introduction
6.2 In Vivo
6.3 In Vitro
7 Global Monoclonal Antibodies Market, By Indication
7.1 Introduction
7.2 Hematological Disorders
7.3 Autoimmune Diseases
7.4 Cancer
7.5 Infectious Diseases
7.6 Neurology
7.7 Cardiovascular
7.8 Microbial Diseases
7.9 Inflammatory Diseases
7.10 Respiratory Diseases
8 Global Monoclonal Antibodies Market, By Application
8.1 Introduction
8.2 Analytical & Chemical Uses
8.3 Therapeutic
8.4 Diagnostic
9 Global Monoclonal Antibodies Market, By End User
9.1 Introduction
9.2 Research Institutes
9.3 Hospitals & Clinics
10 Global Monoclonal Antibodies Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa
11 Strategic Benchmarking
12 Vendors Landscape
12.1 Abbott Laboratories
12.2 GlaxoSmithKline Plc
12.3 Pfizer
12.4 Novartis International
12.5 Merck & Co Inc
12.6 Johnson & Johnson
12.7 Eli Lilly
12.8 Amgen Inc
12.9 Daiichi Sankyo
12.10 AstraZeneca Plc
12.11 Thermo Fisher Scientific
12.12 Biogen Idec Inc
12.13 Mylan N.V.
12.14 Bayer AG
12.15 F.Hoffman-La Roche Ltd
12.16 Bristol Myers Squibb
List of Data Tables
Table 1 Global Monoclonal Antibodies Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
Table 3 Global Monoclonal Antibodies Market Outlook, By Human (2016-2026) ($MN)
Table 4 Global Monoclonal Antibodies Market Outlook, By Humanized (2016-2026) ($MN)
Table 5 Global Monoclonal Antibodies Market Outlook, By Recombinant (2016-2026) ($MN)
Table 6 Global Monoclonal Antibodies Market Outlook, By Chimeric (2016-2026) ($MN)
Table 7 Global Monoclonal Antibodies Market Outlook, By Murine (2016-2026) ($MN)
Table 8 Global Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
Table 9 Global Monoclonal Antibodies Market Outlook, By In Vivo (2016-2026) ($MN)
Table 10 Global Monoclonal Antibodies Market Outlook, By In Vitro (2016-2026) ($MN)
Table 11 Global Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
Table 12 Global Monoclonal Antibodies Market Outlook, By Hematological Disorders (2016-2026) ($MN)
Table 13 Global Monoclonal Antibodies Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
Table 14 Global Monoclonal Antibodies Market Outlook, By Cancer (2016-2026) ($MN)
Table 15 Global Monoclonal Antibodies Market Outlook, By Infectious Diseases (2016-2026) ($MN)
Table 16 Global Monoclonal Antibodies Market Outlook, By Neurology (2016-2026) ($MN)
Table 17 Global Monoclonal Antibodies Market Outlook, By Cardiovascular (2016-2026) ($MN)
Table 18 Global Monoclonal Antibodies Market Outlook, By Microbial Diseases (2016-2026) ($MN)
Table 19 Global Monoclonal Antibodies Market Outlook, By Inflammatory Diseases (2016-2026) ($MN)
Table 20 Global Monoclonal Antibodies Market Outlook, By Respiratory Diseases (2016-2026) ($MN)
Table 21 Global Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
Table 22 Global Monoclonal Antibodies Market Outlook, By Analytical & Chemical Uses (2016-2026) ($MN)
Table 23 Global Monoclonal Antibodies Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 24 Global Monoclonal Antibodies Market Outlook, By Diagnostic (2016-2026) ($MN)
Table 25 Global Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
Table 26 Global Monoclonal Antibodies Market Outlook, By Research Institutes (2016-2026) ($MN)
Table 27 Global Monoclonal Antibodies Market Outlook, By Hospitals & Clinics (2016-2026) ($MN)
Table 28 North America Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
Table 29 North America Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
Table 30 North America Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
Table 31 North America Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
Table 32 North America Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
Table 33 North America Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
Table 34 Europe Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
Table 35 Europe Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
Table 36 Europe Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
Table 37 Europe Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
Table 38 Europe Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
Table 39 Europe Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
Table 40 Asia Pacific Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
Table 41 Asia Pacific Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
Table 42 Asia Pacific Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
Table 43 Asia Pacific Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
Table 44 Asia Pacific Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
Table 45 Asia Pacific Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
Table 46 South America Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
Table 47 South America Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
Table 48 South America Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
Table 49 South America Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
Table 50 South America Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
Table 51 South America Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)
Table 52 Middle East & Africa Monoclonal Antibodies Market Outlook, By Country (2016-2026) ($MN)
Table 53 Middle East & Africa Monoclonal Antibodies Market Outlook, By Source Type (2016-2026) ($MN)
Table 54 Middle East & Africa Monoclonal Antibodies Market Outlook, By Production Type (2016-2026) ($MN)
Table 55 Middle East & Africa Monoclonal Antibodies Market Outlook, By Indication (2016-2026) ($MN)
Table 56 Middle East & Africa Monoclonal Antibodies Market Outlook, By Application (2016-2026) ($MN)
Table 57 Middle East & Africa Monoclonal Antibodies Market Outlook, By End User (2016-2026) ($MN)